Our Mission

Enabling rapid and high quality targeted sequencing and moving precision medicine forward

At Paragon Genomics, we develop and commercialize rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing (NGS) markets. Our proprietary CleanPlex™ background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, simple, and cost effective. Our technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.

Who We Are

At Paragon Genomics, we are a passionate and dedicated team of people whose goal is to provide cutting-edge technologies and solutions to the global genomic research and application community and move precision medicine forward. The team is composed of industry veterans and academic experts who previously worked with well-known industry leading companies and institutions such as Affymetrix, Novartis, Applied Biosystems, Siemens Healthcare, Stanford and Harvard.

Paragon Genomics team also proudly graduated from the California Life Sciences Institute’s (CLSI) Spring 2016 FAST Advisory Program! 

The Team

Tao Chen
Tao ChenChief Executive Offier, Co-founder
Harvard Business School, Peking University
Prior Leadership Experience: Thermo Fisher Scientific, Life Technologies, Pfizer
Dr. Zhitong Liu
Dr. Zhitong LiuPresident and CTO, Co-founder
Rockefeller University, University of South Carolina
Prior Leadership Experience: Thermo Fisher Scientific, Life Technologies, Siemens Healthcare
Dr. Guoying Liu
Dr. Guoying LiuChief Bioinformatics Officer
Stanford University, University of Washington
Prior Leadership Experience: Thermo Fisher Scientific, Novartis, Affymetrix
Jeffrey Liu
Jeffrey LiuDirector of R&D and Operations
Peking Union Medical College, Wuhan University
Prior Leadership Experience: MD Anderson Cancer Center